<VariationArchive VariationID="2691789" VariationName="NM_004465.2(FGF10):c.234dup (p.Trp79fs)" VariationType="Duplication" Accession="VCV002691789" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-30" DateCreated="2024-02-04" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2852811" VariationID="2691789">
      <GeneList>
        <Gene Symbol="FGF10" FullName="fibroblast growth factor 10" GeneID="2255" HGNC_ID="HGNC:3666" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="44300247" stop="44389420" display_start="44300247" display_stop="44389420" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="44305096" stop="44388783" display_start="44305096" display_stop="44388783" Strand="-" />
          </Location>
          <OMIM>602115</OMIM>
          <Haploinsufficiency last_evaluated="2022-02-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FGF10">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-02-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FGF10">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004465.2(FGF10):c.234dup (p.Trp79fs)</Name>
      <CanonicalSPDI>NC_000005.10:44388448:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5p12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="44388448" stop="44388449" display_start="44388448" display_stop="44388449" variantLength="1" positionVCF="44388448" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="44388550" stop="44388551" display_start="44388550" display_stop="44388551" variantLength="1" positionVCF="44388550" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <OtherNameList>
        <Name>1-BP DUP, 234C</Name>
      </OtherNameList>
      <ProteinChange>W79fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.44388449dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.44388449dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.44388551dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.44388551dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011446.1" sequenceAccession="NG_011446" sequenceVersion="1" change="g.5234dup">
            <Expression>NG_011446.1:g.5234dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004465.2" sequenceAccession="NM_004465" sequenceVersion="2" change="c.234dup" MANESelect="true">
            <Expression>NM_004465.2:c.234dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004456.1" sequenceAccession="NP_004456" sequenceVersion="1" change="p.Trp79fs">
            <Expression>NP_004456.1:p.Trp79fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004465.1" sequenceAccession="NM_004465" sequenceVersion="1" change="c.234dupC">
            <Expression>NM_004465.1:c.234dupC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="602115.0008" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004465.2(FGF10):c.234dup (p.Trp79fs) AND Lacrimoauriculodentodigital syndrome 3" Accession="RCV003493405" Version="2">
        <ClassifiedConditionList TraitSetID="82295">
          <ClassifiedCondition DB="MedGen" ID="C5774287">Lacrimoauriculodentodigital syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-04" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">37077496</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="82295" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="66699" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LADD syndrome 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lacrimoauriculodentodigital syndrome 3</ElementValue>
                <XRef ID="MONDO:0859578" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LADD3</ElementValue>
                <XRef Type="MIM" ID="620193" DB="OMIM" />
              </Symbol>
              <XRef ID="C5774287" DB="MedGen" />
              <XRef ID="MONDO:0859578" DB="MONDO" />
              <XRef Type="MIM" ID="620193" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7918694" SubmissionDate="2024-02-01" DateLastUpdated="2024-03-10" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="602115.0008_LADD SYNDROME 3" title="FGF10, 1-BP DUP, 234C_LADD SYNDROME 3" />
        <ClinVarAccession Accession="SCV004242299" DateUpdated="2024-03-10" DateCreated="2024-02-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a multigenerational Chinese family segregating LADD syndrome (LADD3; 620193), Zhang et al. (2023) identified heterozygosity for a duplication of cytosine at nucleotide 234 (c.234dupC, NM_004465.1) in the FGF10 gene, resulting in a trp79-to-leu substitution with a frameshift downstream (Trp79LeufsTer15). The variation was detected in 6 affected family members and 2 unaffected members (the proband's mother and maternal aunt), indicating incomplete penetrance. The mutation was identified by whole-exome sequencing and confirmed by Sanger sequencing. The mutation was expected to cause protein truncation or mRNA degradation through nonsense-mediated mRNA decay.</Attribute>
              <Citation>
                <ID Source="PubMed">37077496</ID>
              </Citation>
              <XRef DB="OMIM" ID="620193" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FGF10" />
          </GeneList>
          <Name>FGF10, 1-BP DUP, 234C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 234C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602115.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LADD SYNDROME 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7918694" TraitType="Disease" MappingType="Name" MappingValue="LADD SYNDROME 3" MappingRef="Preferred">
        <MedGen CUI="C5774287" Name="Lacrimoauriculodentodigital syndrome 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

